Efficacy and tolerability of voriconazole in the treatment of pulmonary aspergillosis Source: Eur Respir J 2007; 30: Suppl. 51, 301s Year: 2007
Clinical efficacy and safety of micafungin in patients with pulmonary aspergillosis Source: Eur Respir J 2006; 28: Suppl. 50, 788s Year: 2006
Treatment of chronic pulmonary aspergillosis by voriconazole compared with micafungin Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009
Effectiveness of itraconazole and systemic steroids in the treatment of ABPA Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018
A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma Source: Eur Respir J, 52 (3) 1801159; 10.1183/13993003.01159-2018 Year: 2018
Itraconazole and allergic bronchopulmonary aspergillosis: long-term follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 432s Year: 2001
Efficacy and safety of Linezolid in pneumonias Source: Eur Respir J 2002; 20: Suppl. 38, 420s Year: 2002
Evaluation of the efficacy and safety of levofloxacin in the treatment of resistant pulmonary tuberculosis; a clinical trial Source: Eur Respir J 2002; 20: Suppl. 38, 546s Year: 2002
Evaluation of the efficacy and safety of moxifloxacin in the treatment of drug-resistant pulmonary tuberculosis; a clinical trial Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis Year: 2008
Invasive pulmonary aspergillosis: What is the role of surgery in the voriconazole era? Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012
Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide Source: Eur Respir J 2002; 20: 127-133 Year: 2002
Pulmonary toxicity to mesalazine Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018
Retrospective study on the combined use of voriconazole and prednisolone in the treatment of acute allergic bronchopulmonary aspergillosis (ABPA). Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019
Clinical efficacy of oral sildenafil therapy in the treatment of pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 347s Year: 2007
Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis Source: Eur Respir J 2012; 40: 271-273 Year: 2012
Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice Source: ERJ Open Res, 4 (4) 00049-2018; 10.1183/23120541.00049-2018 Year: 2018
Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety Source: Eur Respir Rev, 29 (155) 190151; 10.1183/16000617.0151-2019 Year: 2020
Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis Source: Eur Respir J 2011; 38: 1145-1150 Year: 2011
Caspofungin to treat invasive pulmonary aspergillosis in sarcoidosis Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012
Treatment of chronic necrotizing pulmonary aspergillosis (CNPA) with micafungin (MCFG) Source: Eur Respir J 2005; 26: Suppl. 49, 410s Year: 2005